UK markets closed

Appili Therapeutics Inc. (APLIF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0259-0.0000 (-0.15%)
As of 09:30AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
1,150
334.177
1,391
0
199.106
Operating expenses
Research development
5,743
3,810
21,456
10,872
3,021
Selling general and administrative
3,272
4,439
4,613
4,788
3,310
Total operating expenses
4,943
8,110
25,006
14,372
5,644
Operating income or loss
-3,793
-7,776
-23,615
-14,372
-5,445
Interest expense
1,698
1,096
1,555
69.836
12.109
Total other income/expenses net
198.33
-364.606
56.817
-
-
Income before tax
-5,271
-9,207
-25,080
-14,325
-5,416
Income tax expense
67.501
36.392
38.459
0
-
Income from continuing operations
-5,338
-9,243
-25,118
-14,325
-5,416
Net income
-5,338
-9,243
-25,118
-14,325
-5,416
Net income available to common shareholders
-5,338
-9,243
-25,118
-14,325
-5,416
Basic EPS
-0.06
-0.08
-0.38
-0.24
-0.16
Diluted EPS
-0.06
-0.08
-0.38
-0.24
-0.16
Basic average shares
121,246
113,732
66,731
59,179
34,326
Diluted average shares
121,246
113,732
66,731
59,179
34,326